企業プロフィール · Healthcare

GE HealthCare Technologies Inc.

GEHC · 米国株
取引所
米国株
国 / 地域
USA
上場日
2023年1月4日
従業員数
54,000
公式サイト
www.gehealthcare.com
現在値
$61.59
リアルタイム · 2026年6月18日
ベイリー成長スコア
43/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $61.59 リアルタイム · 保守的レンジと妥当レンジの間

総合バリュエーションレンジ · 保守的 $50–$58 / 妥当 $65–$80 / 楽観的 $95–$110。$61.59 時点で 保守的レンジと妥当レンジの間。

レポート公開時 $64.33(2026年5月22日)

この銘柄のレポートはお使いの言語でまだありません。

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

時価総額$278.17億
売上高(TTM)$209.79億
EBITDA$35.22億
純利益率9.1%
ROE19.46%
PER (TTM)14.66
予想PER12.53
PEG1.73
EPS$4.17
配当利回り0.22%
52週レンジ$58.75 – $89.69
アナリスト目標株価$79.72
アナリスト評価4.3 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。